glp-1 osteoarthritis Natural Discovery Hidden in Joints Could Revolutionize Arthritis Treatment Glucagon-like peptide and its receptor

19 :1-5 Key words: type 2 diabetes, cardiovascular outcome studies, pioglitazone, SGLT2 inhibitors, GLP-1 receptor agonist In previous editorials 1-4 we proposed that metformin, pioglitazone, sodium glucose transporter 2 (SGLT2) inhibitors (in particular empagliflozin and canagliflozin) and long-acting glucagon-like peptide-1 (GLP-1) receptor agonists (in particular liraglutide) in combination could complement each other to prevent cardiovascular events and save lives in patients with type 2 diabetes at high cardiovascular risk

( Epub 2021/06/04 )

Asparagine enhances LCK signalling to potentiate CD8(+) T-cell activation and anti-tumour responses

Could GLP-1s curb cravings for things other than food

However, despite their effectiveness, GLP-1 agonists are not without drawbackshigh cost, gastrointestinal side effects, long-term dependency, and concerns about sustainability once the drug is discontinued

Antiangiogenic effects and therapeutic targets of azadirachta indica leaf extract in endothelial cells